Ann: GBM Agile Update, page-29

This post from Stock Twits the other day caught my attention.

illdefinedmind
7/29/22, 12:01 AM
$KTRA $KZIA "looks like almost all of the GCAR North American sites have stopped recruiting as of July 15th. Only Henry Ford and the Cleveland Clinic are still recruiting and I believe that's because they've started recruiting for the 2 new arms already (I know Henry Ford was the launch site for the 2 new arms). Interested to see what this means for trial timelines"

IMO, paxalisib's PI3K/mTOR pathway will used in various combinations for the treatment of patients through precision genetics.

Regards.